335 related articles for article (PubMed ID: 17488279)
21. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats.
Hasegawa Y; Suzuki H; Sozen T; Rolland W; Zhang JH
Stroke; 2010 Feb; 41(2):368-74. PubMed ID: 19940275
[TBL] [Abstract][Full Text] [Related]
22. Sphingosine-1-phosphate-induced airway hyper-reactivity in rodents is mediated by the sphingosine-1-phosphate type 3 receptor.
Trifilieff A; Fozard JR
J Pharmacol Exp Ther; 2012 Aug; 342(2):399-406. PubMed ID: 22570366
[TBL] [Abstract][Full Text] [Related]
23. Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology.
Brinkmann V
Pharmacol Ther; 2007 Jul; 115(1):84-105. PubMed ID: 17561264
[TBL] [Abstract][Full Text] [Related]
24. Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools.
Salomone S; Potts EM; Tyndall S; Ip PC; Chun J; Brinkmann V; Waeber C
Br J Pharmacol; 2008 Jan; 153(1):140-7. PubMed ID: 18026125
[TBL] [Abstract][Full Text] [Related]
25. High density lipoprotein stimulated migration of macrophages depends on the scavenger receptor class B, type I, PDZK1 and Akt1 and is blocked by sphingosine 1 phosphate receptor antagonists.
Al-Jarallah A; Chen X; González L; Trigatti BL
PLoS One; 2014; 9(9):e106487. PubMed ID: 25188469
[TBL] [Abstract][Full Text] [Related]
26. Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy.
Groves A; Kihara Y; Chun J
J Neurol Sci; 2013 May; 328(1-2):9-18. PubMed ID: 23518370
[TBL] [Abstract][Full Text] [Related]
27. Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis.
Lee CW; Choi JW; Chun J
Arch Pharm Res; 2010 Oct; 33(10):1567-74. PubMed ID: 21052934
[TBL] [Abstract][Full Text] [Related]
28. Mapping pathways downstream of sphingosine 1-phosphate subtype 1 by differential chemical perturbation and proteomics.
Gonzalez-Cabrera PJ; Hla T; Rosen H
J Biol Chem; 2007 Mar; 282(10):7254-64. PubMed ID: 17218309
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of cell motility observed with high doses of sphingosine 1-phosphate or phosphorylated FTY720 involves RGS2 through its interactions with the receptor S1P.
Kohno T; Igarashi Y
Genes Cells; 2008 Jul; 13(7):747-57. PubMed ID: 18513330
[TBL] [Abstract][Full Text] [Related]
30. Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors.
Cui QL; Fang J; Kennedy TE; Almazan G; Antel JP
Glia; 2014 Aug; 62(8):1361-75. PubMed ID: 24810969
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological characterization of lysophospholipid receptor signal transduction pathways in rat cerebrocortical astrocytes.
Rao TS; Lariosa-Willingham KD; Lin FF; Palfreyman EL; Yu N; Chun J; Webb M
Brain Res; 2003 Nov; 990(1-2):182-94. PubMed ID: 14568343
[TBL] [Abstract][Full Text] [Related]
32. S1P analogues SEW2871, BAF312 and FTY720 affect human Th17 and Treg generation ex vivo.
Zehra Okus F; Busra Azizoglu Z; Canatan H; Eken A
Int Immunopharmacol; 2022 Jun; 107():108665. PubMed ID: 35255303
[TBL] [Abstract][Full Text] [Related]
33. Sphingosine-1-phosphate and the immunosuppressant, FTY720-phosphate, regulate detrusor muscle tone.
Watterson KR; Berg KM; Kapitonov D; Payne SG; Miner AS; Bittman R; Milstien S; Ratz PH; Spiegel S
FASEB J; 2007 Sep; 21(11):2818-28. PubMed ID: 17449719
[TBL] [Abstract][Full Text] [Related]
34. Effect of FTY720-phosphate on the expression of inflammation-associated molecules in astrocytes in vitro.
Janssen S; Schlegel C; Gudi V; Prajeeth CK; Skripuletz T; Trebst C; Stangel M
Mol Med Rep; 2015 Oct; 12(4):6171-7. PubMed ID: 26239526
[TBL] [Abstract][Full Text] [Related]
35. The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity.
Sawicka E; Dubois G; Jarai G; Edwards M; Thomas M; Nicholls A; Albert R; Newson C; Brinkmann V; Walker C
J Immunol; 2005 Dec; 175(12):7973-80. PubMed ID: 16339533
[TBL] [Abstract][Full Text] [Related]
36. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
Walter DH; Rochwalsky U; Reinhold J; Seeger F; Aicher A; Urbich C; Spyridopoulos I; Chun J; Brinkmann V; Keul P; Levkau B; Zeiher AM; Dimmeler S; Haendeler J
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):275-82. PubMed ID: 17158356
[TBL] [Abstract][Full Text] [Related]
37. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
[TBL] [Abstract][Full Text] [Related]
38. S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures.
Sheridan GK; Dev KK
Glia; 2012 Mar; 60(3):382-92. PubMed ID: 22108845
[TBL] [Abstract][Full Text] [Related]
39. Individual variation of human S1P₁ coding sequence leads to heterogeneity in receptor function and drug interactions.
Obinata H; Gutkind S; Stitham J; Okuno T; Yokomizo T; Hwa J; Hla T
J Lipid Res; 2014 Dec; 55(12):2665-75. PubMed ID: 25293589
[TBL] [Abstract][Full Text] [Related]
40. Activation of the lung S1P(1) receptor reduces allergen-induced plasma leakage in mice.
Blé FX; Cannet C; Zurbruegg S; Gérard C; Frossard N; Beckmann N; Trifilieff A
Br J Pharmacol; 2009 Nov; 158(5):1295-301. PubMed ID: 19785648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
